Literature DB >> 789258

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.

E Klein, H Ben-Bassat, H Neumann, P Ralph, J Zeuthen, A Polliack, F Vánky.   

Abstract

The K562 cell line derived from a CML patient in blast crisis was examined for properties of B and T lymphocytes and cell lines. K562 lacks the B markers of immunoglobulins, Epstein-Barr virus (EBV) genome and associated nuclear antigen, and receptors for EBV. A low proportion of cells from rosettes with sheep erythrocytes, the frequency of which is considerably increased after neuraminidase treatment. Unlike B lines but like T lines, K562 cells are lysed rapidly by C'/Fc receptor-positive human blood leukocytes and do not stimulate MLC reactions. On the other hand, K562 lacks T antigen, high radiosensitivity and sensitivity to growth inhibition by thymidine. The cells do not contain N-APase, an enzyme found in all lines derived from lymphoid cells and in lymphoproliferative diseases. By scanning electron microscopy, K562 cells were seen to be rounded and relatively smooth, with small numbers of short microvilli resembling undifferentiated leukemic cells. A few cells had narrow ridge-like profiles and small ruffles similar to granulocytic leukemic cells. K562 is strongly positive for immunoglobuln Fc receptors and pinocytosis, but does not phagocytose or mediate antibody-dependent phagocytosis or cytolysis. Among histochemical stains, K562 is positive for esterase, lipid, and acid phosphatase. There seems to be no doubt that K562 is not a B cell line. While it has some T cell properties, these are not exclusive. Some of its characteristics indicate that it is probably not lymphoid. Due to its low level of differentiation, its nature cannot be stated with certainty. On the basis of the possible presence of the cellular marker of chronic myeloid leukemia, the Ph chromosome, it may be regarded as belonging to the granulocytic series of cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789258     DOI: 10.1002/ijc.2910180405

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  86 in total

Review 1.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 3.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

4.  MPT0B002, a novel microtubule inhibitor, downregulates T315I mutant Bcr-Abl and induces apoptosis of imatinib-resistant chronic myeloid leukemia cells.

Authors:  Yi-Yen Yeh; Jing-Ping Liou; Yueh-Lun Lee; John Yi-Chung Lin; Huei-Mei Huang
Journal:  Invest New Drugs       Date:  2017-03-27       Impact factor: 3.850

5.  A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma.

Authors:  Rajeev K Tyagi; Rajesh Parmar; Naisargee Patel
Journal:  Hum Vaccin Immunother       Date:  2016-11-30       Impact factor: 3.452

6.  Trans acting regulation of beta globin gene expression in erythroleukemia (K562) cells.

Authors:  K Young; M Donovan-Peluso; R Cubbon; A Bank
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

7.  HERG1 currents in native K562 leukemic cells.

Authors:  María S Cavarra; Silvana M del Mónaco; Yanina A Assef; Cristina Ibarra; Basilio A Kotsias
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

8.  Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy.

Authors:  Hui-Wen Yan; Wei-Xin Hu; Jie-Ying Zhang; Ye Wang; Kun Xia; Min-Yuan Peng; Jing Liu
Journal:  Tumour Biol       Date:  2014-02-15

9.  Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.

Authors:  S Gupta; G Fernandes; M Nair; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.

Authors:  W L Sibbitt; P M Mathews; A D Bankhurst
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.